scholarly journals Pityriasiform Eruption Post COVID Vaccine

COVID 19 pandemic appeared in the end of 2019 and swept throughout the world at a raging speed. Multiple vaccines have been rolled out to curb the spread of disease. We report a case of 43-year male whole developed a generalised eruption with a pityriasiform reaction on histology. The rash resolved with symptomatic treatment.

Author(s):  
Yogesh Chand Yadav ◽  
Ramakant Yadav ◽  
Sushant Kumar

The SARS-CoV-2 virus was first detected in Wuhan, China in December 2019 and was known to produce acute severe respiratory illness in humans which rapidly spread almost throughout the world within a few months. This human coronavirus has seven strains and they commonly produce illness in the nervous system, respiratory system and hepato- intestinal systems. This present review is an attempt to illustrate recent reports pertaining to the management of SARS-CoV-2. Further, it also highlights the diagnosis and clinical management of COVID-19. Various search engines like Scopus, Pubmed and WHO databases were accessed and literature on current advances about COVID-19 including structural features, replication, possible pathogenic, symptoms, diagnosis, prognosis, methods of prevention and possible therapeutic agents used for treatment of patients was reviewed. Current studies indicate that COVID-19 is very infectious with droplet transmission potential. The key modalities to prevent the infection is by keeping social distancing, respiratory/hand hygiene, detection of infection and subsequent quarantine of the infected persons. Presently, either no vaccine for prevention or specific treatments available, however, COVID-19 patients may be managed by using some repositioned drugs and symptomatic treatment.


2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Pramon Viwattanakulvanid

PurposeAs the world faces a new health crisis threatening people with the spread of Covid-19, this study aims to summarize the key information of Covid-19 related to disease characteristics, diagnosis, treatment and prevention along with the lessons learned from Thailand.Design/methodology/approachThe narrative review was synthesized from various sources such as the World Health Organization; Centers for Disease Control and Prevention; Ministry of Public Health and other related news; articles in ScienceDirect, PubMed, Google Scholar; and the author's perspective regarding the lessons learned from Thailand with keywords of “Covid-19” and “Coronavirus” from January to August 2020. Google Trends was used to set common questions.FindingsCovid-19 is the seventh family of coronaviruses that cause various symptoms related to respiratory systems. The disease can be treated through general and symptomatic treatment, by using antiviral drugs. As of July 2020, there are four potential vaccine candidates ChAdOx1 nCoV-19, mRNA-1273, Ad5-nCOV and BNT162b1. The recommendations for Covid-19 prevention are physical distancing, face masks, eye protection and hand washing. Thailand is now considered as low-risk for Covid-19 possibly because of (1) soft policy by government actions, (2) village health volunteers, (3) integration of technology and (4) fact-based communications.Originality/valueThis study summarized the key points about Covid-19, clarified some misunderstandings and shared strategic actions from Thailand, which can be adapted according to the different capacities and situations in other countries.


Author(s):  
Frederic H. Brucato ◽  
Daniel E. Benjamin

Alz heimer’s disease (AD) continues to threaten aged individuals and health care systems around the world. Human beings have been trying to postpone, reduce, or eliminate the primary risk factor for AD, aging, throughout history. Despite this, there is currently only symptomatic treatment for AD and this treatment is limited to only a handful of FDA approved AD drugs.


2021 ◽  
Vol 14 (2) ◽  
pp. 577-581
Author(s):  
Luis Darío-Martínez- Gamez ◽  
Elva Adelina Ibarra-Valencia ◽  
María Angélica Meza-Ledesma ◽  
Gilberto Flores-Vargas ◽  
Efraín Navarro-Olivos ◽  
...  

The first reinfection in the world in Hong Kong, later in Europe (Holland, Belgium) and USA, was documented. In Mexico until November 2020 there are no medical articles that tell us about reinfection; in Celaya Guanajuato the case of a female patient presented with symptoms of COVID-19, 2 polymerase chain reaction in real time tests are performed, in the Laboratory of Public Health from Guanajuato State in an interval of time, less than 5 months; the first in June 2020, with a positive result, received symptomatic treatment and isolation at home for 14 days, negative IgG antibodies test 38 days later; the second time, she presented clinical data on COVID-19 in November From 2020. It was not find references about re-infections by SARS-CoV-2 in Mexico; in Celaya Guanajuato was presented the case of female patient who has symptoms of COVID-19, with new positive PCR, required hospitalization and high-flow oxygen therapy when presenting with pneumonia, was performed simple chest Computing tomography, IgG and IgM antibodies.The evolution was good with discharge from hospitalization 72 hours after admission, continuing his outpatient management until discharge.


2021 ◽  
pp. 18-29
Author(s):  
Abhishek Kumar ◽  
Akash Kumar Giri ◽  
Bibek Kattel

The COVID-19 pandemic resulted in the halt of proper dental care in most of the world, except for emergency cases. And, this resulted in a lot of people seek some home remedies for relieve in dental pain. So, this article aims to list down herbal home remedies which can be very helpful in such conditions. The use of medicinal herbs for dental pain can be traced back to history in some form or the other in almost every country. These herbal home remedies have no significant side effects as compared to other chemical-based alternatives, are also easy to obtain and cheaper as well. Clove, Olive, Miswak, Babool and other herbs listed in the article have significant dental properties which have been validated scientifically through various researches. These plant products can be hence used in commercial products as well but only after proper clinical trials. Further research should be encouraged in this field as herbal alternatives can be very beneficial with no such side effects. However, these home remedies are only useful for symptomatic treatment and undergoing proper dental care is advised.


2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Izabela Czapska-Pietrzak ◽  
Elżbieta Studzińska-Sroka ◽  
Wiesława Bylka

Cinnamon, the bark of different species of cinnamon, is a food spice used all over the world. In medicine, cinnamon is recommended for dyspeptic conditions, fullness and flatulence, for symptomatic treatment of mild diarrhea and for the support of diabetes treatment. Cinnamon contains essential oil, whose main active ingredient is cinnamaldehyde, as well as procyanidins and terpenes. The paper presents the results of experiments performed on animals with induced diabetes assessing the antidiabetic activity of the extract, cinnamon bark oil and cinnamaldehyde. They are also described regarding spasmolytic, analgesic and cardiovascular stimulating activity.


Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Zahid Dar ◽  
Lucky Chauhan ◽  
Monika Chauhan ◽  
Navpreet Kaur ◽  
Tanzeer Kaur ◽  
...  

: The world has been pushed to the edge of a precipice commonly been addressed to as Coronavirus S (SARSCoV2), one of the world’s most widespread viral pandemic in recent times. Many studies are underway and investigating the new role of existing drugs, exploring the safety and efficacy of recently developed vaccines,after getting detailed insights into the behavioural characteristics of SARS-CoV2. Presently supportive &symptomatic treatment along with practices like disease surveillance, contact tracing, and early diagnosis mayhelp control the future of COVID-19 outbreaks. Effort has been made to compile the information about coronavirus; its clinical manifestations, differential diagnosis, preventive aspects, and therapeutic options as a review.


2019 ◽  
Vol 20 (4) ◽  
Author(s):  
Izabela Czapska ◽  
Elżbieta Studzińska-Sroka ◽  
Wiesława Bylka

Cinnamon, the bark of various species of cinnamon, is used in the food spice used throughout the world. In medicine, cinnamon bark and bark oil are used for dyspeptic ailments, fullness and bloating, and cinnamon bark products are recommended as helpful in symptomatic treatment of mild diarrhea also are recommended to support the treatment of diabetes. Cinnamon contains essential oil, whose main active ingredient is cinnamaldehyde, as well as procyanidins, terpenes. This paper presents the results of in vitro experiments on antidiabetic action, along with the mechanism of this activity as well as on antimicrobial, anti-inflammatory and cytotoxic also presented. This article also contains information on the dosage of cinnamon bark and cinnamon bark oil.


1992 ◽  
Vol 4 (3) ◽  
pp. 5-7 ◽  
Author(s):  
Barry Reisberg ◽  
Gerald Oppenheim

Alzheimer's disease (AD) is now recognized as a major cause of morbidity and mortality in elderly populations throughout the world. Tragically, no clearly effective treatment for this major illness entity has emerged. In part, the lack of an effective treatment is the result of an absence of fundamental knowledge regarding the etiology and pathogenesis of the illness. However, treatment implies the amelioration of symptoms, not cure. In other neuropsychiatric illnesses such as schizophrenia, major depression, and idiopathic Parkinson's disease, there is a similar absence of knowledge regarding etiology and, to a greater or lesser extent, regarding pathogenesis. Nevertheless, symptomatic treatment for these other neuropsychiatric illnesses is available. The same potential for symptomatic treatment exists in AD. The absence of consensus or systematic information regarding treatment in AD is in large part due to the failure to apply appropriate methodologies to symptomatic assessment and pharmacologic treatment.


2019 ◽  
pp. 64-67
Author(s):  
S. V. Ryazantsev ◽  
A. A. Krivopalov ◽  
S. A. Rebrova ◽  
L. I. Krivopalova

Allergic rhinitis is one of the most common human diseases and causes a deterioration of the quality of life. The prevalence of allergic rhinitis in the Russian Federation and in the world has increased significantly. The main pharmacological group in the treatment of allergic rhinitis is the 2nd generation antihistamines with high affinity for H1-receptors. The article presents an overview of the new representative of the abovementioned group of drugs - the drug bilastine (Nixar®). 


Sign in / Sign up

Export Citation Format

Share Document